- The older cancer survivor population is predicted to increase substantially, an estimated 42% over the next decade.
- Nature reports that draft guidelines for nanomedicine are being developed and that with hundreds of nanoproducts currently being tested in humans, the recommendations aim to safeguard trial participants.
- A Conversation with Dr. Jane Perlmutter about the Role of Advocates in Cancer Research.
- Open-access R&D could be one answer to drug industry woes.
- The New York Times takes on the controversy of prostate cancer screening.
MSKCC in the News: September 22 – October 10
- Crain’s reported that MSKCC’s proposed Westchester cancer center plan was approved by the Public House and Planning Council.
- Dr. Peter B. Bach of MSKCC was quoted in a New York Times article about a recent study published in Lancet that examines the rate of operations performed on Medicare recipients in the final year of life.
- The Memorial Sloan-Kettering Brooklyn Infusion Center received the Award of Excellence in the 26th annual Modern Healthcare Design Awards.
Johns Hopkins ABX (Antibiotic) Guide is Now Available
The Library has recently purchased a site license for Johns Hopkins ABX (Antibiotic) Guide. The guide provides evidenced-based information on the treatment of infectious diseases to help you make decisions at the point of care. This web and mobile resource covers details of diagnosis; drug indications, dosing, pharmacokinetics, side effects and interactions; pathogens; management; and vaccines. Continue reading